Investors & Media
Chardan's 9th Annual Genetic Medicines Conference
October 21, 2025
Alexandria Forbes, Ph.D., president and chief executive officer, will be participating on two panel discussions:
In Vivo Gene Therapy for Ocular Diseases: Regulatory Flexibility, Endpoints & Biomarkers
Tuesday at 8:45 a.m. ET
Gene Therapy for neurodegenerative diseases – are we there yet?
Tuesday at 3:30 p.m. ET